About 1,820,673 results (1,036 milliseconds)
Immunotherapy for Small Cell Lung Cancer: Does It Work?
https://news.google.com/__i/rss/rd/articles/CBMiY2h0dHBzOi8vd3d3LmhlYWx0aGxpbmUuY29tL2hlYWx0aC9zbWFsbC1jZWxsLWx1bmctY2FuY2VyL2ltbXVub3RoZXJhcHktZm9yLXNtYWxsLWNlbGwtbHVuZy1jYW5jZXItMtIBAA?oc=5 Jun 1, 2021 ... Many are accepting volunteers to help better understand the relationship between immunotherapy and the prognosis of SCLC. Last medically ...
Extensive-Stage Small Cell Lung Cancer: Gaps in Treatment
https://news.google.com/__i/rss/rd/articles/CBMiW2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZXh0ZW5zaXZlLXN0YWdlLXNtYWxsLWNlbGwtbHVuZy1jYW5jZXItZ2Fwcy1pbi10cmVhdG1lbnTSAQA?oc=5 May 26, 2021 ... ... stage, or metastatic small cell lung cancer ... life, cause pain, and cause neurological symptoms if they have brain metastases.
Maisha Chowdhury - Google Scholar
https://scholar.google.com/citations?user=5xrcGRkAAAAJ&hl=en Outcomes with non-small cell lung cancer and brain-only metastasis. S Schmid ... small cell lung cancer (NSCLC) patients presenting with brain-only metastatic ...
Brain Metastases from Colorectal Cancer: Microenvironment and ...
http://feedproxy.google.com/~r/google/GJns/~3/AEXkoH6rXk0/15784 Once diagnosed with brain metastasis, the patient's prognosis is not promising, with less than 6 months survival expectancy. Several prognostic factors for ...
Taletrectinib Signals Activity in ROS1-Positive Non–Small Cell Lung ...
https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L3RhbGV0cmVjdGluaWItc2lnbmFscy1hY3Rpdml0eS1pbi1yb3MxLXBvc2l0aXZlLW5vbi1zbWFsbC1jZWxsLWx1bmctY2FuY2Vy0gEA?oc=5 Sep 27, 2021 ... All patients must test positive for ROS1 fusions, have an ECOG performance status of 0 or 1, measurable disease, a life expectancy of at least 3 ...
TTFields Plus SOC Meets Primary End Point in Stage IV NSCLC ...
https://news.google.com/__i/rss/rd/articles/CBMihQFodHRwczovL3d3dy5vbmNsaXZlLmNvbS92aWV3L3R0ZmllbGRzLXBsdXMtc29jLW1lZXRzLXByaW1hcnktZW5kLXBvaW50LWluLXN0YWdlLWl2LW5zY2xjLWFmdGVyLWZhaWx1cmUtb2YtcGxhdGludW0tYmFzZWQtY2hlbW90aGVyYXB50gEA?oc=5 Jan 5, 2023 ... Novocure announces pivotal LUNAR study in non-small cell lung cancer met primary overall survival endpoint. News release. Novocure. January ...
Trastuzumab Deruxtecan Yields Robust Antitumor Responses in ...
https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvdHJhc3R1enVtYWItZGVydXh0ZWNhbi15aWVsZHMtcm9idXN0LWFudGl0dW1vci1yZXNwb25zZXMtaW4taGVyMi1uc2NsY9IBAA?oc=5 Sep 18, 2021 ... ... prognosis and an increased incidence of brain metastasis. A ... for HER2 mutant metastatic non-small cell lung cancer. News release ...
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple ...
https://news.google.com/__i/rss/rd/articles/CBMi1QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDQwNzAwNjAyNy9lbi9GREEtQXBwcm92ZXMtVHJvZGVsdnklQzIlQUUtdGhlLUZpcnN0LVRyZWF0bWVudC1mb3ItTWV0YXN0YXRpYy1UcmlwbGUtTmVnYXRpdmUtQnJlYXN0LUNhbmNlci1TaG93bi10by1JbXByb3ZlLVByb2dyZXNzaW9uLUZyZWUtU3Vydml2YWwtYW5kLU92ZXJhbGwtU3Vydml2YWzSAQA?oc=5 Apr 7, 2021 ... ... metastatic breast cancer and metastatic non-small cell lung cancer. ... life-threatening diseases, including HIV, viral hepatitis and cancer.
Limited Success Seen in the Second-Line for SCLC
https://news.google.com/__i/rss/rd/articles/CBMiUWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2xpbWl0ZWQtc3VjY2Vzcy1zZWVuLWluLXRoZS1zZWNvbmQtbGluZS1mb3Itc2NsY9IBAA?oc=5 Oct 27, 2022 ... ... for extensive stage small cell lung cancer. FDA. May 16, 2024 ... brain radiation affects lifespan in patients with small cell lung cancer.
Thomas William Lycan Jr. - Google Scholar
https://scholar.google.com/citations?user=x376NR0AAAAJ&hl=en ... for metastatic non–small-cell lung cancer in clinical practice. LES ... for non-small cell lung cancer brain metastases. M Abdulhaleem, H Johnston, R ...
US10434157B2 - Therapeutic multi-peptides T specific immune ...
https://patents.google.com/patent/US10434157B2/en Patients with advanced NSCLC (non-small-cell lung carcinoma) relapsing after chemotherapy generally have a poor prognosis, particularly in the case of patients ...
Dimitrios Makrakis, MD - Google Scholar
https://scholar.google.com/citations?user=NLuKUbsAAAAJ&hl=en Outcome of patients with NSCLC and brain metastases treated with immune checkpoint inhibitors in a 'real-life ... metastatic non-small cell lung cancer (NSCLC) ...
Non-invasive biomarker could aid with earlier diagnosis of breast ...
https://news.google.com/__i/rss/rd/articles/CBMigwFodHRwczovL3d3dy5uZXdzLW1lZGljYWwubmV0L25ld3MvMjAyMjA4MTYvTm9uLWludmFzaXZlLWJpb21hcmtlci1jb3VsZC1haWQtd2l0aC1lYXJsaWVyLWRpYWdub3Npcy1vZi1icmVhc3QtY2FuY2VyLW1ldGFzdGFzaXMuYXNweNIBAA?oc=5 Aug 16, 2022 ... Zhang, D.X., et al. (2022) αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by ...
ESMO: AstraZeneca's targeted lung cancer med Tagrisso slashes ...
https://news.google.com/__i/rss/rd/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzdHJhemVuZWNhLXMtdGFyZ2V0ZWQtbHVuZy1jYW5jZXItbWVkLXRhZ3Jpc3NvLXNsYXNoZXMtY25zLXJlY3VycmVuY2UtYnktODLSAQA?oc=5 Sep 19, 2020 ... Once EGFR-mutated lung cancer spreads to the brain, a patient's prognosis ... small cell lung cancer targeted drugs AstraZeneca Tagrisso Pharma ...
Chardin David - Google Scholar
https://scholar.google.com/citations?user=hhX2KYMAAAAJ&hl=en ... metastatic non-small cell lung cancer. O Humbert, M Bauckneht, J Gal, M Paquet, D Chardin, D Rener, ... European Journal of Nuclear Medicine and Molecular ...
Trastuzumab Deruxtecan Impresses With Clinical Activity in HER2 ...
https://news.google.com/__i/rss/rd/articles/CBMiaWh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvdHJhc3R1enVtYWItZGVydXh0ZWNhbi1pbXByZXNzZXMtd2l0aC1jbGluaWNhbC1hY3Rpdml0eS1pbi1oZXIyLW11dGFudC1uc2NsY9IBAA?oc=5 Sep 18, 2021 ... Enhertu granted breakthrough therapy designation in the US for HER2 mutant metastatic non-small cell lung cancer. News release. Daiichi ...
Orazio Caffo - Google Scholar
https://scholar.google.com/citations?user=MZiJ_CYAAAAJ&hl=en Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non—small-cell lung cancer ...
US10413522B2 - Methods for treating brain metastasis - Google ...
https://patents.google.com/patent/US10413522B2/en Certain non-limiting embodiments provide for a method for inhibiting growth and/or survival of metastatic cancer cells in the brain of a subject, comprising ...
US20190322715A1 - Novel peptides and combination of peptides ...
https://patents.google.com/patent/US20190322715A1/en ... for use in immunotherapy against small cell lung cancer and other cancers - Google Patents ... brain metastases free survival (Huang et al., 2015a). TOP2A ...
Durvalumab Combos Yield Better Reponses Than Monotherapy ...
https://news.google.com/__i/rss/rd/articles/CBMihQFodHRwczovL3d3dy5jYW5jZXJuZXR3b3JrLmNvbS92aWV3L2R1cnZhbHVtYWItY29tYm9zLXlpZWxkLWJldHRlci1yZXBvbnNlcy10aGFuLW1vbm90aGVyYXB5LXRyZWF0bWVudC1pbi11bnJlc2VjdGFibGUtc3RhZ2UtaWlpLW5zY2xj0gEA?oc=5 Nov 11, 2022 ... Patients with unresectable stage III non-small cell lung cancer derived the most benefit from durvalumab when combined with either oleclumab ...